Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (CFEAS- AC) for the Treatment of Symptomatic Atrial Fibrillation

NCT00958165 is registered in ClinicalTrials.gov with CardioFocus as lead sponsor.

NCT NCT00958165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00958165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (CFEAS- AC) for the Treatment of Symptomatic Atrial Fibrillation
Lead sponsor
CardioFocus
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2009
Completion date
May 31, 2012
Enrollment
81 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation